Pain Prescriber Education Programs Need Better Coordination, GAO Says
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA and other federal agencies could better coordinate their efforts to educate prescribers about prescription pain reliever abuse, the Government Accountability Office said.
You may also be interested in...
Opioid Prescriber Education Mandate Could Be Added To User Fee Bill
Sen. Rockefeller introduces amendment that would require 16 hours of training every three years to maintain DEA registration.
Senate User Fee Bill Heads To Mark-up Without Track-And-Trace
Manager’s amendment released in lead-up to committee mark-up still does not include drug tracking provisions, but will expand advisory committee recruiting and eliminate conflict of interest waivers using language in Rep. Burgess’ bill.
Actavis’ MoxDuo: Can A Generic Firm Drive Growth With A Low-Dose Product?
Actavis aims to replace its Kadian pain franchise through a deal with QRxPharma for a fixed-dose combination of morphine and oxycodone.